載入...
Microbial therapeutics: New opportunities for drug delivery
With >40 clinical trials underway, we are nearing the first FDA-approved live microbial therapeutic. Here, Giovanni Traverso, MIT and Harvard Medical School Assistant Professor, and colleagues Miguel Jimenez and Institute Professor Robert Langer from MIT discuss the significant challenges of admi...
Na minha lista:
| 發表在: | J Exp Med |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Rockefeller University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504217/ https://ncbi.nlm.nih.gov/pubmed/31028093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20190609 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|